Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non –Burkitt Aggressive B-cell Lymphoma
Non –Burkitt B-cell lymphoma with a rearrangement of MYC is an aggressive lymphoma that can fail initial treatment. We reviewed the data from 28 patients and investigated whether the mid-treatment positron emission tomography/computed tomography (PET/CT) scan could predict treatment failure. The results of that PET/CT scan did not predict in which patients the initial treatment would fail. Therefore, it should not be used to guide treatment decisions in this population.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Hua-Jay J. Cherng, Rachel Lynn Sargent, Sunita Dwivedy Nasta, Jakub Svoboda, Stephen J. Schuster, Anthony R. Mato, April Schrank-Hacker, Jennifer J.D. Morrissette, Daniel J. Landsburg Tags: Original Study Source Type: research
More News: Burkitt Lymphoma | CT Scan | Hematology | Leukemia | Lymphoma | Myeloma | PET Scan | Study